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The Editorial on the Research Topic 
Roles of Ion Channels in Immune Cells
Ion channels are critical membrane proteins controlling a wide variety of cellular signaling events 
in many different cell types. In classical excitable cells, voltage-sensitive ion channels have well-
described roles in the regulation of action potentials and contraction events. In non-excitable cells 
such as circulating or tissue-resident cells of the immune system, ion channels have lesser described 
roles in controlling cell biology. However, through enhanced pharmacological tools and gene knock-
outs, we are now beginning to appreciate the plethora of cellular events in immune cells that are 
controlled by a variety of ion channels (1). The goal of this research topic was to highlight some of 
the recent advances in understanding which ion channels are important and are under investigation 
for novel therapeutics. This collection of six articles covers microglia, myeloid cells, and lymphocytes 
and provides updates and insights into the roles of various channels in these cells.
Mortadza and colleagues review the latest evidence supporting a functional role for transient 
receptor potential melastatin (TRPM) 2 ion channels in the immune system (Syed Mortadza et al.). 
TRPM2 ion channels are activated by increases in reactive oxygen species (ROS) leading to Ca2+ 
signals in a range of immune cells. The authors discuss the use of TRPM2 knockout mice revealing 
an important role in the immune system and inflammatory diseases. Based on these studies in mouse 
models, the authors highlight a negative role for TRPM2 in colitis, ischemia-/reperfusion-mediated 
tissue damage, and neuropathic and inflammatory pain. They also discuss the importance of TRPM2 
in inflammatory signaling including NLRP3 inflammasome activation leading to inflammatory 
cytokine production including bioactive interleukin (IL)-1β and chemokine-dependent dendritic 
cell function. Overall, the review demonstrates the importance of TRPM2 as a future therapeutic 
target for the treatment of inflammatory disease.
Stebbing and colleagues provide a mini-review of numerous ion channels expressed in microglia 
(Stebbing et  al.). Ligand-gated channels belonging to P2X and N-methyl-d-aspartate (NMDA) 
receptor families respond to the neurotransmitters adenosine triphosphate (ATP) and glutamate, 
respectively. These are involved in the sensing of local microenvironments within the central nervous 
system and can affect microglial activation states through modulation of intracellular Ca2+ levels. 
In addition, K+ channels are also implicated in microglial responses including proliferation, nitric 
oxide generation, and cytokine secretion and, as such, are potential therapeutic targets for increasing 
neuroprotection in neurodegenerative disorders such as Alzheimer’s disease.
Through an original research article, Ferreira and colleagues describe the regulation of the 
intermediate conductance Ca2+-activated K+ channel, KCa3.1, by cyclic guanosine monophosphate 
(cGMP)-dependent protein kinase (PKG) via a pathway involving ROS and Ca2+/calmodulin-
dependent protein kinase II (CaMKII) in microglia (Ferreira et al.) KCa3.1 is widely expressed in 
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immune cells, but knowledge of KCa3.1 in microglia is hitherto 
limited. Through pharmacological approaches, and the use of the 
rat MLS-9 microglial cell line and alternative-activated primary 
rat microglia, the authors demonstrate that elevation in cGMP 
activates PKG to promote mitochondrial ROS formation. This 
in turn stimulates endoplasmic reticulum Ca2+ release, which 
subsequently binds to calmodulin to both open the KCa3.1 
channel and activate CaMKII to increase KCa3.1 activity through 
a second, unknown mechanism. The authors propose that this 
process may serve as a positive feedback mechanism to promote 
KCa3.1-dependent responses in microglia under conditions such 
as oxidative stress.
Moving to the adaptive immune system, Davenport and 
colleagues have reviewed the current understanding of the CaV1 
subfamily of L-type voltage-gated Ca2+-channels expressed by 
lymphocytes (Davenport et al.). The authors discuss the evidence 
supporting the expression of CaV1 ion channels in immune cells 
including a rare genetic disease (Timothy Syndrome) that sug-
gests a role for CaV1.2 in human immune responses. Evidence 
for CaV1 function in B lymphocytes is largely supported by phar-
macological studies, and the authors present further evidence 
for the expression of CaV1 ion channels in B lymphocytes using 
a CaV1.3 deficient chicken DT40 B cell line. It is concluded that 
CaV1 channels play an important role in the immune system; 
however, there are many unanswered questions particularly sur-
rounding the potential activation mechanism of immune CaV1 
channels.
Nohara and colleagues review the current understanding of 
the complex orchestration of Ca2+ responses in T lymphocytes 
and recent advances in understanding store-operated calcium 
channels (STIM/Orai), TRP channels, NMDA receptors, P2X 
receptors, and CaV channels in T lymphocytes (Nohara et  al.). 
The authors focus on CaV channels for which there is growing 
evidence particularly from the recent use of CaV1 channel subunit 
knockout mice where significant effects are observed on T lympho-
cyte responses. The potential interplay between CaV and STIM 
proteins in T cells is discussed, and the complexity surrounding 
regulation of intracellular (Ca2+) in these cells is highlighted. The 
authors conclude by identifying that superior immunomodula-
tors may be developed targeting lymphocyte-specific variants of 
ion channels and these may be highly beneficial in future treat-
ments for autoimmune diseases or immunosuppression required 
for transplants.
Finally, Rissiek and colleagues review the P2X7 receptor, an 
ATP-gated cation channel, in murine T lymphocytes (Rissiek 
et  al.). The authors highlight that both extracellular ATP and 
nicotinamide adenine dinucleotide (NAD) can activate P2X7 
on murine T lymphocytes. In contrast to ATP, P2X7 activation 
by NAD requires covalent adenosine triphosphate (ADP)-
ribosylation catalyzed by the ecto-ADP-ribosyltransferase 
ARTC2.2. Notably, NAD activates only the splice isoform P2X7k 
and the main P2X7 subtype within murine T lymphocytes. The 
authors describe the roles of P2X7 in murine (and human) T cells 
including IL-2 production, shedding of cell surface receptors, 
and cell death. Lastly, the authors highlight that ATP and NAD is 
released during T cell isolation, which results in the preferential 
loss of T regulatory and natural killer T cells due to high P2X7 
expression on these cells, and outline ways in which to circumvent 
this to improve the quality of ex vivo T cell preparations.
Collectively, this Frontiers in Immunology Research Topic 
provides a sample of the diversity and importance of ion chan-
nels in immune cells. We are grateful to each author and trust 
that this Research Topic will serve as a prompt to continue future 
investigations of ion channels in immune cells.
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